69 related articles for article (PubMed ID: 393160)
1. Role of macrophage activation in allograft immunity: in vivo studies.
Debray-Sachs M; Dy M; Hamburger J
Ann Immunol (Paris); 1979; 130C(5):721-33. PubMed ID: 393160
[TBL] [Abstract][Full Text] [Related]
2. Macrophage cytotoxicity in the mouse immune response against a skin allograft.
Dimitriu A; Dy M; Thomson N; Hamburger J
J Immunol; 1975 Jan; 114(1 Pt 1):195-9. PubMed ID: 122985
[TBL] [Abstract][Full Text] [Related]
3. Two types of allograft-induced cytotoxic macrophage, one against allografts and the other against syngeneic or allogeneic tumor cells.
Yoneda Y; Tashiro-Yamaji J; Kubota T; Yoshida R
Microbiol Immunol; 2008 Jul; 52(7):349-56. PubMed ID: 18667033
[TBL] [Abstract][Full Text] [Related]
4. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
Yoshida R; Yoneda Y; Kuriyama M; Kubota T
J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
Margenthaler JA; Landeros K; Kataoka M; Flye MW
Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
[TBL] [Abstract][Full Text] [Related]
6. Targeted gene disruption of the heat shock protein 72 gene (hsp70.1) in the donor tissue is associated with a prolonged rejection-free survival in the murine skin allograft model.
Oh KH; Kim JY; Kim D; Lee EM; Oh HY; Seo JS; Han JS; Kim S; Lee JS; Ahn C
Transpl Immunol; 2004 Dec; 13(4):273-81. PubMed ID: 15589740
[TBL] [Abstract][Full Text] [Related]
7. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
[TBL] [Abstract][Full Text] [Related]
8. Cell-mediated allograft responses in vitro. VI. Studies on macrophage-mediated cytotoxicity.
Pfizenmaier K; Trostmann H; Röllinghoff M; Wagner H
Immunology; 1975 Dec; 29(6):967-76. PubMed ID: 1081494
[TBL] [Abstract][Full Text] [Related]
9. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
Koch U; Choksi S; Marcucci L; Korngold R
J Immunol; 1998 Jul; 161(1):421-9. PubMed ID: 9647252
[TBL] [Abstract][Full Text] [Related]
10. Humoral immunity in allograft rejection. The role of cytotoxic alloantibody in hyperacute rejection and enhancement of rat cardiac allografts.
Oluwole SF; Tezuka K; Wasfie T; Stegall MD; Reemtsma K; Hardy MA
Transplantation; 1989 Nov; 48(5):751-5. PubMed ID: 2815247
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the mechanism of active enhancement of renal allograft survival by blood transfusion.
Quigley RL; Wood KJ; Morris PJ
Immunology; 1988 Mar; 63(3):373-81. PubMed ID: 2965097
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection.
Felix NJ; de Serres S; Meyer AA; Ting JP
J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017
[TBL] [Abstract][Full Text] [Related]
13. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
Hurrell SM; Zarling JM
J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of a human lymphokine which renders macrophages cytotoxic.
Gougerot MA; Dimitriu A; Dy M; Legrand L; Hamburger J
Ann Immunol (Paris); 1977; 128C(3):621-32. PubMed ID: 141238
[TBL] [Abstract][Full Text] [Related]
15. [Cytotoxic lymphocytes after allostimulation in vivo: kinetic, reproducibility and specificity after primary stimulation (author's transl)].
Schulze HA; Brock J; Siegl E; Günther J
Allerg Immunol (Leipz); 1980; 26(4):310-8. PubMed ID: 6452040
[TBL] [Abstract][Full Text] [Related]
16. Non-H-2 histocompatibility antigens encoded by Moloney-murine leukemia virus in Mov mouse strains are detectable by skin grafting and cytolytic T lymphocytes.
Wettstein PJ; Colombo MP; Jaenisch R
J Immunol; 1988 Jun; 140(12):4337-41. PubMed ID: 3286772
[TBL] [Abstract][Full Text] [Related]
17. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.
Kawase I; Komuta K; Namba M; Yokota S; Ogura T; Kishimoto S
Cancer Res; 1986 Mar; 46(3):1047-54. PubMed ID: 3510719
[TBL] [Abstract][Full Text] [Related]
18. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
[TBL] [Abstract][Full Text] [Related]
19. Intrathymic injection of donor-specific X-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats.
Binder J; Sayegh MH; Watschinger B; Hancock WW; Kupiec-Weglinski JW
Transplantation; 1994 Jul; 58(1):80-6. PubMed ID: 8036712
[TBL] [Abstract][Full Text] [Related]
20. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
Gao L; Woo J; Buelow R
J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
